Seungjean Chai to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Seungjean Chai has written about Antimetabolites, Antineoplastic.
Connection Strength
0.056
-
Morris SA, Moore DC, Musselwhite LW, Lopes KE, Hamilton A, Steuerwald N, Hanson SL, Larck C, Swift K, Smith M, Kadakia KC, Chai S, Hwang JJ, Patel JN. Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center. Am J Health Syst Pharm. 2023 Sep 22; 80(19):1342-1349.
Score: 0.056